Global site navigation

Local editions

GSK profit drops in first quarter on higher costs
Economy

GSK profit drops in first quarter on higher costs

by  AFP 1 min read

British drugmaker GlaxoSmithKline on Wednesday said its net profit fell 23 percent in the first quarter as the company faced higher exceptional costs compared with a year earlier.

PAY ATTENTION: The 2024 Business Leaders Awards Present Entrepreneurs that Change Nigeria for the Better. Check out their Stories!

Profit after tax dropped to £1.08 billion ($1.35 billion) , GSK said in an earnings statement.

The fall came despite sales its drugs sales rising 10 percent to £7.4 billion.

GSK chief executive Emma Walmsley said the quarter saw further progress in final trials of new drugs.

"We have strengthened prospects for growth in all of our key therapeutic areas this quarter: infectious diseases, HIV, respiratory/immunology and oncology," she said in the statement.

Following the update, the group's share price edged up 0.1 percent in early trading on London's top-tier FTSE 100 index, as the group also upgraded its full-year outlook for sales.

Read also

Starbucks points to weaker consumer as profit falls

"GSK has started 2024 in rude health. Strong growth in vaccine and speciality medicines drove a double digit rise in group sales," noted Derren Nathan, head of equity research at Hargreaves Lansdown.

PAY ATTENTION: 2024 Business Leaders Awards - Find Out Business Names in Nigeria Driving Changes

The first quarter saw GSK agree to buy Aiolos Bio for up to $1.4 billion, with a focus on an asthma medication still at the testing stage.

bcp/tw

© Agence France-Presse

Source: AFP

Authors:
AFP avatar

AFP AFP text, photo, graphic, audio or video material shall not be published, broadcast, rewritten for broadcast or publication or redistributed directly or indirectly in any medium. AFP news material may not be stored in whole or in part in a computer or otherwise except for personal and non-commercial use. AFP will not be held liable for any delays, inaccuracies, errors or omissions in any AFP news material or in transmission or delivery of all or any part thereof or for any damages whatsoever. As a newswire service, AFP does not obtain releases from subjects, individuals, groups or entities contained in its photographs, videos, graphics or quoted in its texts. Further, no clearance is obtained from the owners of any trademarks or copyrighted materials whose marks and materials are included in AFP material. Therefore you will be solely responsible for obtaining any and all necessary releases from whatever individuals and/or entities necessary for any uses of AFP material.

Hot: